These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8262965

  • 1. Role of the membrane in the inactivation of factor Va by activated protein C.
    Kalafatis M, Mann KG.
    J Biol Chem; 1993 Dec 25; 268(36):27246-57. PubMed ID: 8262965
    [Abstract] [Full Text] [Related]

  • 2. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M, Rand MD, Mann KG.
    J Biol Chem; 1994 Dec 16; 269(50):31869-80. PubMed ID: 7989361
    [Abstract] [Full Text] [Related]

  • 3. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO, Kalafatis M, Mann KG.
    Protein Sci; 1997 Sep 16; 6(9):2016-27. PubMed ID: 9300501
    [Abstract] [Full Text] [Related]

  • 4. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM, Kalafatis M, Cushman M, Tracy RP, Mann KG, Tracy PB.
    J Biol Chem; 1995 Sep 01; 270(35):20794-800. PubMed ID: 7657663
    [Abstract] [Full Text] [Related]

  • 5. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
    Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J.
    J Biol Chem; 1995 Sep 08; 270(36):21158-66. PubMed ID: 7673148
    [Abstract] [Full Text] [Related]

  • 6. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain.
    Mann KG, Hockin MF, Begin KJ, Kalafatis M.
    J Biol Chem; 1997 Aug 15; 272(33):20678-83. PubMed ID: 9252387
    [Abstract] [Full Text] [Related]

  • 7. Loss of membrane-dependent factor Va cleavage: a mechanistic interpretation of the pathology of protein CVermont.
    Lu D, Kalafatis M, Mann KG, Long GL.
    Blood; 1994 Aug 01; 84(3):687-90. PubMed ID: 8043858
    [Abstract] [Full Text] [Related]

  • 8. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF, Kalafatis M, Shatos M, Mann KG.
    Arterioscler Thromb Vasc Biol; 1997 Nov 01; 17(11):2765-75. PubMed ID: 9409254
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the molecular defect in factor VR506Q.
    Kalafatis M, Bertina RM, Rand MD, Mann KG.
    J Biol Chem; 1995 Feb 24; 270(8):4053-7. PubMed ID: 7876154
    [Abstract] [Full Text] [Related]

  • 10. A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition.
    Hockin MF, Cawthern KM, Kalafatis M, Mann KG.
    Biochemistry; 1999 May 25; 38(21):6918-34. PubMed ID: 10346914
    [Abstract] [Full Text] [Related]

  • 11. The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function.
    Kalafatis M, Mann KG.
    J Biol Chem; 2001 May 25; 276(21):18614-23. PubMed ID: 11278331
    [Abstract] [Full Text] [Related]

  • 12. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
    Bakker HM, Tans G, Janssen-Claessen T, Thomassen MC, Hemker HC, Griffin JH, Rosing J.
    Eur J Biochem; 1992 Aug 15; 208(1):171-8. PubMed ID: 1387359
    [Abstract] [Full Text] [Related]

  • 13. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J, Hoekema L, Nicolaes GA, Thomassen MC, Hemker HC, Varadi K, Schwarz HP, Tans G.
    J Biol Chem; 1995 Nov 17; 270(46):27852-8. PubMed ID: 7499257
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.
    Smirnov MD, Safa O, Regan L, Mather T, Stearns-Kurosawa DJ, Kurosawa S, Rezaie AR, Esmon NL, Esmon CT.
    J Biol Chem; 1998 Apr 10; 273(15):9031-40. PubMed ID: 9535891
    [Abstract] [Full Text] [Related]

  • 17. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
    Gierula M, Salles-Crawley II, Santamaria S, Teraz-Orosz A, Crawley JTB, Lane DA, Ahnström J.
    J Thromb Haemost; 2019 Dec 10; 17(12):2056-2068. PubMed ID: 31364267
    [Abstract] [Full Text] [Related]

  • 18. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.
    Lu D, Kalafatis M, Mann KG, Long GL.
    Blood; 1996 Jun 01; 87(11):4708-17. PubMed ID: 8639840
    [Abstract] [Full Text] [Related]

  • 19. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
    Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB.
    Blood; 1998 Apr 15; 91(8):2818-29. PubMed ID: 9531592
    [Abstract] [Full Text] [Related]

  • 20. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M, Haley PE, Lu D, Bertina RM, Long GL, Mann KG.
    Blood; 1996 Jun 01; 87(11):4695-707. PubMed ID: 8639839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.